MOMOSTOCKS (MOMO)

[Golden Cross]

💲$TWOH .0029 Multi Day Runner Possibilities Here!

[ProfitScout]

$CYCU News: Cycurion Reports Full Year 2024 Financial Results
Adjusted EBITDA of $2.3 million (+59% y/y); Generated $1.2 million of Net Income
News Link:
https://www.globenewswire.com/news-release/2025/04/17/3063348/0/en/Cycurion-Reports-Full-Year-2024-Financial-Results.html

[ProfitScout]

$CYCU News: Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency

FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case management and operational solutions for justice agencies worldwide. Together, the companies have been awarded a $22 million multi-year contract to deliver a state-of-the-art criminal justice case management system to a State Police agency, reinforcing Cycurion’s leadership in securing critical justice infrastructure.

The web-based solution, powered by Journal Technologies’ robust eSeries Framework platform, provides comprehensive case management, tracking, and reporting capabilities. Designed to streamline the initiation, planning, execution, control, and reporting of prosecution and investigative activities, the system prioritizes cybersecurity resilience to protect sensitive data and operations from escalating cyber threats. With decades of justice-sector expertise embedded in the eSeries Framework, the platform delivers document management, workflow automation, database organization, forms processing, and seamless third-party integrations enhanced by Cycurion’s cutting-edge security expertise.

“Cycurion’s partnership with Journal Technologies provides the tools to empower the State Police with a solution that not only optimizes operational efficiency but also sets a new standard for cybersecurity in the justice sector,” said Kevin Kelly, CEO of Cycurion, Inc. “This collaboration reflects our commitment to safeguarding critical systems while driving innovation across the offender life cycle.”

AI-Powered Cybersecurity Expansion
This landmark contract aligns with Cycurion’s strategic vision to expand its cybersecurity business, with artificial intelligence (AI) at the core of its growth strategy. By embedding AI-driven capabilities into its justice-sector offerings, Cycurion is redefining how government and law enforcement agencies combat cyber threats. The company’s Cyber Shield MSSP (Managed Security Service Provider) solution, now enhanced with AI, delivers advanced threat detection, automated response protocols, and predictive vulnerability analysis—ensuring unparalleled protection for mission-critical operations. This $22 million engagement underscores Cycurion’s dedication to scaling its AI-powered cybersecurity solutions, cementing its position as a market leader in delivering transformative, high-impact security to the public sector.

Drawing on its extensive experience in integrated justice and data administration, Cycurion strengthens the eSeries Framework with industry-leading security measures. As an active member of the Integrated Justice Information Systems (IJIS) Institute, the National Sheriff’s Association, and standards committees of the National Information Exchange Model (NIEM), Cycurion shapes the future of secure data exchange and justice technology. The Cyber Shield MSSP solution offers tailored, AI-enhanced protections across the offender life cycle, safeguarding sensitive data and operations in an increasingly digital world.

About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies, Cloudburst Security, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients with a commitment to securing the digital future.

Forward looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.

Many factors could cause Cycurion’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements described in this press release, including words such as “continue”, “expect”, “intend”, “will”, “hope”, “should”, “would”, “may”, “potential”, and other similar expressions. Such factors could include, among others, those detailed in its Registration Statement on Form S-4, as filed with the Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in that filing with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and Cycurion does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. Cycurion cannot assure that such statements will prove to be accurate as actual results, and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Investor Contact:
CORE IR
[e-mail]

Media Contact:
Phone: [phone]
Email: [e-mail]

[Mrspencers]

$CBLO: The volume speaks volumes—1.4M shares traded with buyers in full control. No sell pressure, just quiet accumulation at $0.01.

The fundamentals are stacking up: 14MW crypto mining buildout, a powerful JV with CoinEdge, and exposure to Cardano ($ADA). This isn't just hype—it's a setup.

Low float. Real blockchain expansion. Momentum brewing. $CBLO could be gearing for its next leg up.

[I am done]

$SFWJ Medcana, exports of its first pharmaceutical-grade CBD crop
https://finance.yahoo.com/news/sfwj-medcana-announces-successful-export-164000200.html

[Think1st]

LWLG NEWS

Friday morning PR:

https://s3.amazonaws.com/b2icontent.irpass.cc/2586/rl144468.pdf

https://www.lightwavelogic.com/news/press-releases/

[seventhcircle]

$RONN 52 week lows

We’re excited to share that we will provide more details about our meeting in Scottsdale, with Virgina Gateway Region Executives announced yesterday, in the coming days. Stay tuned! https://t.co/M9RfsGxIWi$RONN

— RONN inc ($RONN) (@leepharma) March 19, 2025

[Four by Two]

SING up 44% on high volume

[I am done]

$BULT Bullet Blockchain Exclusive Partnership Unveils First-Of-Its-Kind Crypto Wallet Protection for Bitcoin ATMs Nationwide
https://www.globenewswire.com/news-release/2025/03/19/3045361/0/en/Bullet-Blockchain-and-Sailo-Technologies-Partner-to-Set-a-New-Standard-in-Bitcoin-ATM-Security-and-Fraud-Prevention.html

[WALL STREET KID]

Lytus Technologies Holdings $LYT Reports 24% Revenue Growth and Returns to Profitability in Financial Results for Six Months Ended September 30, 2024

https://www.nasdaq.com/articles/lytus-technologies-holdings-reports-24-revenue-growth-and-returns-profitability-financial

[WALLnut]

RadioGel®: A Revolutionary Cancer Treatment on the Horizon & The Bright Future of IsoPet®

Cancer treatment is on the verge of a major breakthrough with the upcoming IDE approval of RadioGel®, a cutting-edge, targeted radiation therapy. Developed by Vivos Inc., this yttrium-90 (Y-90) based brachytherapy device offers a safer, more effective approach to treating solid tumors. Unlike conventional radiation therapy, which exposes surrounding healthy tissue to radiation, RadioGel® delivers a precise, localized dose directly into the tumor, maximizing its effectiveness while minimizing side effects. Meanwhile, IsoPet®, the veterinary version of this technology, is already proving to be a game-changer in pet oncology, with an even brighter future ahead.


---

Why RadioGel® Will Be a Breakthrough in Human Cancer Treatment

Traditional cancer treatments, such as surgery, chemotherapy, and external beam radiation, come with significant limitations—ranging from long recovery times and severe side effects to damage to healthy tissues near the tumor. RadioGel® eliminates many of these concerns through its minimally invasive, highly targeted approach.

Key Advantages of RadioGel®:

1. Ultra-Precise Tumor Targeting

The hydrogel-based delivery system ensures that the radioactive Y-90 microparticles remain localized within the tumor, preventing radiation from affecting healthy tissue.

This makes it ideal for treating hard-to-reach cancers like liver, pancreatic, prostate, and brain tumors.



2. Minimally Invasive with Short Recovery Time

Unlike surgeries that require extensive recovery, RadioGel® is injected directly into the tumor, allowing patients to return to daily activities almost immediately.

This is particularly beneficial for elderly or high-risk patients who may not be good candidates for surgery.



3. Powerful Yet Short-Lived Radiation

Yttrium-90 has a half-life of just 2.67 days, meaning its radiation effect declines rapidly, reducing long-term exposure risks.

The radiation remains active long enough to destroy the tumor cells, but patients do not remain radioactive for extended periods.



4. Fewer Side Effects, Greater Tolerance

Compared to traditional radiation therapies, which often cause fatigue, nausea, and damage to surrounding organs, RadioGel®'s targeted approach minimizes collateral damage, making it much easier on the patient.





---

What Happens After IDE Approval?

IDE approval will be a major turning point for RadioGel®, allowing it to enter human clinical trials. If successful, the next step will be FDA clearance, leading to widespread adoption in hospitals and oncology centers worldwide.

Additionally, RadioGel®’s approval could position Vivos Inc. as a prime acquisition target for larger pharmaceutical or medical device companies, further accelerating the commercialization and expansion of this technology.

With growing support from the medical community and investors, RadioGel® has the potential to become a preferred treatment for localized tumors, offering a safe, effective alternative to traditional radiation and surgery.


---

IsoPet®: The Future of Veterinary Cancer Treatment

While human trials are on the horizon, IsoPet® is already changing lives in veterinary medicine. This version of RadioGel® is being successfully used to treat cancer in dogs, cats, and even horses—offering hope to pet owners looking for effective alternatives to surgery or chemotherapy.

The Future of IsoPet® Looks Bright:

✔ More Veterinary Clinics Will Adopt IsoPet® – As awareness grows, more veterinary oncologists will offer this treatment, making it widely available for pets across the U.S. and beyond.

✔ Expanding Into International Markets – Additional regulatory approvals will allow IsoPet® to expand into Europe, Asia, and other regions, dramatically increasing its reach.

✔ Potential for Pet Insurance Coverage – With increasing clinical success, pet insurance companies may start covering IsoPet® treatments, making it more affordable for pet owners.


---

Final Thoughts

With RadioGel® moving toward human trials and IsoPet® already improving cancer treatment in pets, Vivos Inc. is positioned at the forefront of a major shift in cancer care. Whether it’s saving human lives or giving beloved pets a second chance, this innovative technology is set to redefine radiation therapy as we know it.

The next few months will be crucial as IDE approval approaches, but one thing is clear: RadioGel® and IsoPet® are here to change the game.

[MythicNebula13]

Nice post!

[I am done]

$PNPN $PNPNF Power Metallic Mines Inc. ranked #4 on the TSX and #1 among mining stocks, Featured
https://www.marketscreener.com/quote/stock/ROCKET-COMPANIES-INC-110535847/news/Rocket-Companies-NYSE-RKT-to-Acquire-Redfin-NASDAQ-RDFN-in-1-75B-Deal-More-Stocks-to-Watch-49302475/

[BadCuda]

STI breaking out , close 12.5 Premarket .19 going to .30 gap fill 

[WALLnut]

Why Invest in RadioGel? The Future of Cancer Treatment. RDGL

RadioGel® is poised to redefine radiation therapy, offering a groundbreaking solution for treating solid tumors with unparalleled precision and safety. Unlike conventional radiation therapy, which exposes healthy tissue to harmful radiation, RadioGel’s injectable hydrogel delivers yttrium-90 beta radiation directly inside the tumor, maximizing treatment effectiveness while minimizing collateral damage.

What Makes RadioGel a Game-Changer?

1. Unmatched Precision, Maximum Impact

RadioGel stays within the tumor, delivering high-dose radiation where it’s needed most. This eliminates the risks associated with systemic radiation exposure.



2. Minimally Invasive, Maximum Safety

Patients receive a simple injection, avoiding the need for high-risk surgeries or external beam radiation, which often damages surrounding organs.

Reduced side effects mean better patient outcomes and improved quality of life.



3. Targeting Inoperable and Hard-to-Treat Cancers

Many tumors are deemed inoperable due to their location or size. RadioGel offers a solution where surgery is not an option, making it a lifeline for patients with limited treatment choices.

Strong potential applications include liver cancer, brain tumors, bone metastases, and sarcomas.



4. Regulatory Momentum & Fast-Track Market Path

Vivos Inc. is working with the FDA to gain approval as a medical device, a significantly faster pathway compared to pharmaceuticals.

Once cleared, hospitals and oncology centers can rapidly adopt RadioGel, creating early revenue streams and broad market penetration.



5. Multi-Billion Dollar Market Opportunity

The global radiation therapy market is projected to exceed $10 billion by 2030, with growing demand for precision-targeted cancer treatments.

As a disruptive innovation, RadioGel has buyout potential, making it an attractive acquisition target for major biotech and oncology firms.




Why Now? The Window of Opportunity

RadioGel is at the forefront of a paradigm shift in oncology. With FDA progress advancing, a clear market need, and a unique competitive edge, early investors have a chance to capitalize before mainstream adoption.

Final Verdict: A High-Impact Investment with Game-Changing Potential

Investing in RadioGel today means backing a first-of-its-kind cancer treatment that could transform radiation therapy worldwide. As demand for safer, more effective cancer solutions grows, RadioGel is positioned to become a cornerstone of future oncology treatment—making this a strategic and high-upside investment opportunity.


RDGL

[antman]

TAJ.V (TAJIF) .07 cents (cad). A gold exploration company with ground in Guyana. It is contiguous to the OKO gold discovery which is almost 8 million ounces total. Tajiri Press Release (I own shares)...

[I am done]

$ECGS Strategic Acquisition: Eco-Growth Strategies, Inc. acquires Hawaiian Isles Water assets, securing a major foothold in Hawaii’s bottled water market.
https://www.prnewswire.com/news-releases/eco-growth-strategies-inc-acquires-assets-of-hawaiian-isles-water-302384337.html

[WALL STREET KID]

$AMC ENTERTAINMENT 4TH QUARTER YEAR END EARNINGS CALL ON NOW

https://investor.amctheatres.com/

[Four by Two]

SING up 18% getting ready to run 🚀

[Nebuchadnezzar]

RITE smack that ask into the 0040s
hope all is well

RITE book value $0.031

1.5x book is price target of $0.0465

[varok]

HAMRF - is on the move!

I have a new exciting junior mining company that you may like.

I have a long history of trading and investing in silver going back 50 years and have been stacking my investing in physical silver with extreme interest. I have always been excited about silver even though many years has been rather difficult to rationalize the commodity and the continued-on slot of parties that short their positions i.e., banks and various Hege funds.

From a past article from the well-known Silver Analyst Mr. Ted Butler - September 21, 2023,

" After 40 years of silver price manipulation and suppression on the COMEX, the physical market has experienced a lack of production growth and enhanced demand brought about by too-low silver prices. According to the immutable law of supply and demand, silver is now in a deepening physical shortage in which sharply higher prices are both required and inevitable. The key element that I speak of today is the likely behavior of the short sellers of silver derivatives. Investors hold 2 billion ounces of silver in industry-standard 1,000-ounce bars and a similar quantity in smaller bars and coins. Since these holdings are owned outright, there is no short position as exists in every derivatives contract, including COMEX futures and options and OTC swap contracts".

This positioning by some may be coming to an end as silver supplies and above ground inventory appears to be held in strong hands. Also, the demand for silver has gained renewed interest due to the industrial side with renewable energy like solar and the tech sector is likely to grow in the next decade and beyond.

There are about 20 grams of silver going into an average solar panel and the demand is only going to continue for the next decade. The investment side of silver is strong with jewelry and parties holding physical silver. India and China have been importing large quantities monthly. China for the production of Solar and India for the jewelry and individual stacking/holding.

The demand for silver is increasing, but the mining of silver is becoming in short supply due to closures with mines having exhausted their existing resources and with a renewed interest to find alternative locations and the current rise in silver prices will begin a new dawn for this metal.

This brings me to Silver Hammer Mining- https://silverhammermining.com

This is a very interesting junior mining company with a well-qualified management team.

As with all mining concerns is the need for capital to put the first shovel in the dirt and Hammer is on a quest to find and incorporate into their company interested parties to advance this next stage. The share price of silver has been a real disappointment over the last decade and VC for this industry has been difficult to bring in. All this is about to change, and the price of silver once again moving higher, as well will bring back in the VC with solid interest. This is where we are at now and I'm sure financing will find its way into Silver Hammer.

Currently for new investors, take a look into their existing 100% owned mines and you will be pleased with their ownership. These are legacy mines in vast acreages in well-known silver belts from the 1800's.

The share structure is absolutely very favorable at 60,653,204 with a MC of 2,223m$. This MC is based on the 4 100% existing mines not what is in the ground. Once the company can achieve their funding, the real MC and the leveraged silver supply inground will dramatically revalue the MC to represent the feasible silver to eventually be mined and inventoried. This step is the most important that we as shareholders are waiting for.

This company is currently under the radar and shares are currently very tightly held.

Put this on your watchlist and do your due diligence, but remember, when the funding is announced the spike will happen and is the way mining issues react.

I believe that the current price range for this company at .05 is worth a position, but at this point in time is still speculative.

I own this company and have been adding for the last 5 years.

Have a good day
varok
Bullish
Bullish

[doogdilinger]

Thanks Neb buddy!

[antman]

TAJ.V = .06 (cad) Tajiri Resources is a gold exploration company with claims in Guyana right in the middle of an 11 million ounce discovery by GTWO.TSX and GMIN.TSX -Press Release

[Nebuchadnezzar]

RITE major consolidation at 0026-0032 for next big push over 0050

then onto .01+

CEO working on unsolicited quotes, form 10, reg A and uplisting

https://mineral-rite.com/investor-relations/

more acquisitions coming

you can ignore me but dont ignore RITE ;)


$$$$$$$$$$$$$$$$$$$$$$$

[Alexulf]

The Brixton Metals Corporation (BBBXF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.7613, representing a +1453.66% increase from the current price of $0.049.

https://investorshub.advfn.com/Brixton-Metals-Corp-BBBXF-31124

[doogdilinger]

ADIA still climbing! Emergent therapeutic stem cell play under accumulation from the subs!

[I am done]

$SPQS OTC Filing out: SportsQuest, FAQ Update on China Cinema Return to SEC Reporting Issuer Status, Strategic Developments and Other Material Events
https://www.otcmarkets.com/otcapi/company/financial-report/421560/content

[Alexulf]

Euro Sun signed an agreement with Glencore Mining!

https://www.eurosunmining.com/investors/#presentation

https://investorshangout.com/Euro-Sun-Mining-...NFF-94022/

[ProfitScout]

$ONAR News: Onar Holding Corporation Announces FINRA Approval for New Name and Ticker Symbol, ONAR

This final step in ONAR's reverse merger journey sets the stage for ambitious growth, strategic acquisitions, and market expansion.

LOS ANGELES, Feb. 3, 2025 /PRNewswire/ -- Reliant Holdings, Inc. (OTCQB: ONAR), a leading marketing technology company and network of marketing agencies, today announced that it has received approval from the Financial Industry Regulatory Authority (FINRA) to formally adopt its new corporate name and change its ticker symbol from RELT to ONAR. Effective immediately, these updates underscore the company's reverse merger completion, forward-looking vision, and commitment to accelerated growth in an increasingly competitive marketplace.

"This transformation marks a significant milestone for our organization," said Claude Zdanow, CEO of ONAR. "By unifying our identity under a single, modernized brand, we're better positioned to pursue our ambitious goals, drive innovation, and deliver exceptional results for our clients, partners, and investors."

A Unified Brand with a Bold Vision

The new corporate name and ticker symbol reflect ONAR's evolution following its reverse merger with Reliant Holdings, Inc. in 2024. This streamlined identity removes confusion and clarifies that ONAR's market presence aligns with its strategic mission: to offer state-of-the-art marketing solutions, blending AI-driven technology with human expertise to help businesses thrive in today's digital landscape.

Key Advantages of the Name Change & Finalization of the Rebrand

Increased Market Visibility: The updated name and ticker symbol help investors and stakeholders easily recognize ONAR and its position as a marketing technology leader and remove the confusion with the Reliant Holdings brand that had no connection to ONAR's business.

Improved Brand Perception: By aligning the company's identity with its current strategy and market positioning, ONAR is confident this will enhance market visibility, improve brand perception, and signal its commitment to growth and innovation.
Milestones Driving Momentum

This updated company identity comes less than one year after ONAR's reverse merger with Reliant Holdings Inc. In the months since the merger, ONAR has achieved significant milestones, including:

Launching ONAR Labs: Introduced Cortex, an AI-powered marketing intelligence platform revolutionizing data-driven decision-making.

CEO Leadership: Claude Zdanow presented their ambitious vision at the 2025 Sequire Investor Summit and NobleCon20.

Strategic Partnerships: Secured a mid-six-figure contract with iQSTEL, Inc. to lead their rebranding and growth initiatives.

Executive Team Expansion: Appointed Patricia Kaelin as Chief Financial Officer and welcomed Sara Scully as corporate communications and marketing leader.

Financial Growth: Achieved robust Q3 2024 results, featuring higher revenue, lower costs, and a stronger cash position.

Acquisitions and Expanded Reach: Acquired and rebranded Of Kos, adding healthcare marketing expertise and expanding their global network.

Shareholder Confidence: Gained formal approval for the name change to Onar Holding Corporation and authorized amendments to fuel future expansion.

Rebranding for Success: Revitalized flagship agency Storia with fresh visuals, emphasizing performance marketing and AI-driven optimization.
These achievements reflect ONAR's commitment to innovation, strategic growth, and leveling the playing field for middle-market and growth-stage companies so they may achieve marketing success in an increasingly competitive landscape.

The team is incredibly proud of the progress made in such a short time and excited for the future as they continue to revolutionize the advertising and marketing industry. ONAR leaders are confident that the company is well-positioned for continued success and look forward to delivering exceptional results for clients, partners, and shareholders in 2025.

About ONAR

ONAR (OTCQB: ONAR) a leading marketing technology company and marketing agency network, now publicly traded as Onar Holding Corporation. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

ONAR has nearly 50 employees across five continents, and it is aggressively expanding its team to support the company's growth and acquisition pipeline. Its agencies service over 45 clients across various industries:

Performance Marketing & SEO: Our high-touch performance marketing agency, Storia, specializes in brand growth, data-driven excellence, and paid advertising.
Full-Service Healthcare Marketing: Partnering with healthcare professionals, Of Kos provides the best possible patient experience and strives to revolutionize the standard of care.
Experiential Marketing & Events: CHALK is an experiential marketing powerhouse of event architects who turn bold ideas into unforgettable reality, designing events that dare to defy the ordinary.
Pioneering Technology Incubator: ONAR Labs is a team of data scientists, engineers, and industry experts who are identifying, developing, and commercializing innovative marketing technology solutions born from servicing our agency clients, battle-tested by our network to ensure real-world applicability and impact.
ONAR's network of agencies focuses on servicing companies ranging from $50M to $1B+ in revenue, and ONAR is actively searching for agencies to acquire and become part of the network.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ONAR's current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. These statements are not historical facts and are inherently uncertain and outside of ONAR's control. Forward-looking statements include, among other things, statements regarding ONAR's expectations regarding its ability to achieve its financial and strategic goals, including surpassing $100 million in revenue and securing a NASDAQ listing; its ability to expand its client base and market share; and its ability to develop and launch new products and services. Actual results may differ materially from ONAR's expectations and projections due to various risks and uncertainties, including market conditions, competition, the ability to protect intellectual property, the ability to manage growth, changes in laws and regulations, and other factors described in ONAR's filings with the Securities and Exchange Commission. These forward-looking statements are made as of the date of this press release, and ONAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/onar-holding-corporation-announces-finra-approval-for-new-name-and-ticker-symbol-onar-302365949.html

SOURCE ONAR

[deri21]

$OPW $OPWEF Opawica Receives Drill Permit On Its 100% Owned Bazooka Property On The Abitibi Green Stone Belt Quebecs
https://www.thenewswire.com/press-releases/1BQPFK484-opawica-receives-drill-permit-on-its-100-owned-bazooka-property-on-the-abitibi-green-stone-belt-quebecs.html

[Four by Two]

SING up 51% on news @ Boston Solar
Just getting started for a banner year

[ProfitScout]

$CBDW News: 1606 Corp. Announces Strategic Partnership With GPOPlus to Enhance AI-Driven Distribution Solutions

SEATTLE, WASHINGTON / ACCESS Newswire / February 4, 2025 / 1606 Corp. (OTC PINK:CBDW), a leading provider of advanced artificial intelligence (AI) solutions, today announced a new strategic partnership with GPO Plus, Inc. (OTCQB:GPOX), an AI-powered Distributor revolutionizing distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model. Under the terms of a new agreement, 1606 Corp. will provide AI-driven services to enhance the functionality, performance, and capabilities of GPOX's PRISM+ platform.

GPOX is known for its innovative technology-driven Direct Store Delivery (DSD) model, which leverages AI to optimize inventory management, streamline deliveries, and drive operational excellence for the convenience store and gas station industries. By further integrating advanced AI solutions, GPOX aims to take its PRISM+ platform to the next level, helping its clients make real-time data-driven decisions, improve customer satisfaction, and increase efficiency and profitability.

"We are excited to partner with GPOX to bring the power of AI to the forefront of their distribution platform," said Austen Lambrecht, CEO of 1606 Corp. "Our AI solutions will further enhance GPOX's current AI usage to enhance its ability to manage complex logistics, optimize inventory, and deliver valuable insights that will transform the way convenience stores and gas stations operate. This collaboration is a testament to 1606 Corp's commitment to delivering cutting-edge AI solutions and creating meaningful value for our partners."

As part of the agreement, 1606 Corp will provide GPOX with the following services:

AI Development & Optimization: Tailored AI solutions designed to optimize the machine learning capabilities and performance of the PRISM+ platform.
Data Integration & Analytics: Seamless integration of diverse data sources such as IoT sensors, weather data, and satellite imagery to drive actionable insights.
Edge Computing: Optimization of AI models and data processing to improve latency and real-time decision-making at the edge.
Training & Support: Comprehensive training for GPOX's team, along with ongoing technical support.
Performance Monitoring & Optimization: Continuous monitoring and enhancement of AI models to ensure maximum efficiency.
GPOX's commitment to revolutionizing distribution aligns with 1606 Corp.'s vision of harnessing AI to solve complex, real-world problems. Together, the two companies will work to redefine the future of the gas station and convenience store supply chain, driving better service, efficiency, and customer outcomes.

Brett H. Pojunis, CEO of GPOX, added, "Our PRISM+ platform has been a game-changer for our distribution business, but we know we've only scratched the surface with what AI can offer. The possibilities AI presents are endless, and this partnership with 1606 Corp. is about discovering how we can reach new heights in operational performance and data-driven decision-making. I'm genuinely excited about the fresh perspectives and solutions they'll bring to the table to find new ways to benefit our clients and partners."

The agreement takes effect immediately, and the development and implementation of the AI solutions are underway. Both companies are enthusiastic about the partnership's potential and the transformative impact it will have on the distribution industry.

For more information about 1606 Corp. and its AI-driven solutions, please visit cbdw.ai and for more on GPOX visit GPOPlus.com

About 1606 Corp.

1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience. As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit cbdw.ai.

Industry Information

The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025, reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.

Forward-Looking Statements

This press release contains "forward-looking statements" that include statements regarding expected financial performance and growth information relating to future events. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its officers and managers, and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company's need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company's products, and other risks that are detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as "may," "will," "can" "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "seek," "estimate," "continue," "plan," "point to," "project," "predict," "could," "intend," "target," "potential," and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reflected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reflect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company's actual results may vary significantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties affecting GPO Plus, Inc. GPOX, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Company Contacts:

1606 Corp. Investor Contacts:
Austen Lambrecht
CEO, 1606 Corp.
[e-mail]
cbdw.ai

GPOX Shareholder Success Team:
Brett H. Pojunis, CEO
Email: [e-mail]
Shareholder's Line: 855.935.GPOX (4769)

SOURCE: 1606 Corp.

[ProfitScout]

$IQST - iQSTEL Releases 2025 Shareholder Letter Highlighting Strategic Growth, M&A 2025 Campaign, and Vision for a $1 Billion Corporation Future

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- iQSTEL Inc. (OTCQX: IQST), a leading innovator in the technology and telecommunications sectors, is pleased to share its 2025 Shareholder Letter, outlining the company's strategic initiatives, financial performance, and bold vision for the future. Below is the full letter from CEO Leandro Iglesias:


Letter to Shareholders

Dear Valued Shareholders,

As we embark on 2025 with great enthusiasm and a bold vision for the future, I am thrilled to share iQSTEL's strategic direction, remarkable achievements, and ambitious goals. Your unwavering trust and confidence inspire us to push boundaries and achieve extraordinary milestones. Together, we are building a company destined for greatness, driven by innovation, profitability, and an unrelenting focus on delivering exceptional shareholder value.

Extraordinary Know-How in M&A

iQSTEL has established itself as an expert in identifying, acquiring, and integrating high-value companies. Over the course of 11 successful venture and acquisitions, we have refined a strategic approach that consistently drives growth and strengthens our position as a leader in the technology and telecommunications industries.

Our most recent acquisition, QXTEL, exemplifies this expertise. From April to December 2024, QXTEL generated $85 million in net revenue and $950,000 in EBITDA, based on preliminary accounting. These results highlight iQSTEL's ability to identify and unlock value, setting the stage for our ambitious M&A campaign in 2025.

A Bold Step Forward: Our M&A 2025 Campaign

This year, iQSTEL is launching an ambitious Mergers and Acquisitions (M&A) campaign designed to accelerate our growth trajectory. Our goal is to acquire a company within the Telecom, Fintech, Cybersecurity, or AI services sectors, generating tens of millions of dollars in revenue and contributing over $1 million EBITDA annually.

We intend to complete this acquisition before reaching NASDAQ, where even greater opportunities await us. To support this campaign and advance our broader business objectives, we have just filed an S-1 registration, reflecting our commitment to securing the resources necessary for transformative growth.

Enhancing Shareholder Value Through Strategic M&A and Organic Growth

At iQSTEL, we place our shareholders at the core of our strategic decisions. Our carefully planned M&A initiatives, combined with robust organic growth, have driven substantial increases in Revenue Per Share (RPS) over recent years:

2020: $0.380
2021: $0.439
2022: $0.577
2023: $0.839
2024 (preliminary accounting): $1.364
This impressive RPS growth trajectory reflects the success of our strategy to create sustainable shareholder value. By pursuing high-margin opportunities through both M&A and organic initiatives, we anticipate maintaining this rapid growth pace.

Our strategy safeguards shareholder value, ensuring that market perceptions align with the underlying strength demonstrated by our growing RPS and improving profitability. This positions iQSTEL as a leader in its industry and strengthens our foundation for sustained success.

Building on Our Momentum in 2025

2024 was a pivotal year for iQSTEL. We achieved critical mass, with our operating businesses generating positive net income quarter after quarter. This success underscores the strength of our strategy and our ability to execute effectively. For 2025, we aim even higher:

Revenue Forecast: $340 million
EBITDA Forecast for our operating business: $3 million
These milestones are more than just numbers—they are a testament to the dedication of our team, the support of our shareholders, and our relentless pursuit of growth. They represent a critical step toward achieving our vision of becoming a $1 billion revenue company with eight-digit positive EBITDA by 2027.

Even More, Continuous Progress and Innovation in 2025

Every day, iQSTEL takes bold steps to strengthen its business and ensure a brighter future:

Rebranding: We are positioning iQSTEL as a technology leader, delivering high-margin, high-tech products to our customers. We have introduced our new logo and plan to share more results from our rebranding collaboration with ONAR.
Cost Reduction and Efficiency: We are implementing strategies to streamline operations, accelerate EBITDA growth, and enhance shareholder value. In the coming days, we will announce further cost-reduction initiatives to bolster profitability.
Cybersecurity Product Launch: Thanks to our strategic partnership with Cycurion, we are set to launch our cybersecurity products this quarter and begin sales in the first half of 2025. This initiative expands our portfolio to address critical global needs.
AI Services Growth: Our AI platform, Airweb.ai, continues to gain customers and partners, underscoring its transformative potential. New AI services will launch in the first half of 2025, reinforcing iQSTEL's reputation as a powerhouse of innovation.
NASDAQ Uplisting: Building a Strong Foundation

Our journey toward a NASDAQ uplisting is progressing steadily and strategically. While we are not rushing, we have been giving time for organic growth to enhance our stock price, supported by the strength of our operating business, forecasted to generate $3 million in EBITDA in 2025.

If the management decided that is the right time to jump into Nasdaq, and we have not achieved yet the organic price will be when the management will decide to expedite the uplisting process through a reverse stock split, at that time we will ensure full transparency by filing an SEC notice. Any reverse stock split, if executed, will be aligned with and in conjunction with the NASDAQ uplisting.

We are committed to building a company that captures the attention of national investors and reflects the immense value we offer.

Management's Commitment: Aligned with Shareholder Interests

At iQSTEL, our leadership team is not just steering the company toward its ambitious goals; we are also deeply invested in its success. As the largest shareholder group, management holds the equivalent of 40.5 million common shares through a combination of common and preferred shares. This significant ownership reflects our unwavering belief in iQSTEL's potential and aligns our interests directly with those of our valued shareholders.

This commitment is a testament to the confidence we have in iQSTEL's vision of becoming a $1 billion revenue corporation by 2027. Our substantial stake in the company ensures that management is fully aligned with long-term value creation. Every strategic decision we make—whether it involves organic growth initiatives, high-margin product expansion, or strategic acquisitions—is driven by a shared goal: to deliver sustainable growth and maximize shareholder value.

The road to achieving our $1 billion revenue milestone is clear, and our investment in iQSTEL underscores our dedication to seeing it through. We are not merely stewards of the company; we are also shareholders, invested in its future and committed to building a prosperous and sustainable enterprise for years to come.

Confidence of Long-Term Investors: Extending Support for a $1 Billion Vision

Our vision of achieving $1 billion in revenue by 2027 is not just a statement—it is a well-defined plan that has garnered the trust and support of long-term investors. Their confidence in our strategic direction is evidenced by their willingness to extend the maturity dates of convertible notes originally used to acquire QXTel in 2024.

These notes, previously set to mature in 2025, now have extended maturity dates through 2026, providing iQSTEL with additional financial flexibility to execute our growth strategy. This extension underscores the belief that we are on a clear trajectory to achieve our ambitious goals and deliver exceptional returns.

Our long-term investors recognize the importance of supporting iQSTEL as we transition to a Nasdaq listing and continue to build momentum towards our revenue and profitability targets. Their ongoing commitment reflects their trust in our ability to execute our plans and deliver on our promises.

A Brilliant Future Ahead

iQSTEL is more than a company—it's a testament to the power of vision, hard work, and innovation. Together, we are creating something extraordinary, a company that delivers exceptional financial results while driving meaningful progress across industries.

This is an incredibly exciting time for iQSTEL. The journey we are on is transformative, and the opportunities ahead are limitless. Thank you for being part of this journey, for believing in our vision, and for sharing in our success. Together, we will achieve extraordinary milestones and secure a bright and prosperous future for iQSTEL and its shareholders.

Warm regards,

Leandro Iglesias
President & CEO, iQSTEL Inc.

About iQSTEL:

iQSTEL Inc. (OTC-QX: IQST) (www.iQSTEL.com) is a US-based multinational publicly listed company in the final stages of the path to becoming listed on NASDAQ. With FY2024 revenues of $277 million based on preliminary accounting, iQSTEL is positioning itself for explosive growth. iQSTEL's mission is to serve basic human needs in today's modern world by making essential tools accessible, regardless of race, ethnicity, religion, socioeconomic status, or identity. The company recognizes that modern human needs such as physiological, safety, relationship, esteem, and self-actualization are marginalized without access to ubiquitous communications, financial freedom, clean, affordable mobility, and information.

iQSTEL has been building a strong business platform with its customers, and by leveraging this trust, the company is now beginning to sell high-tech, high-margin products across its divisions. iQSTEL is strategically positioned to achieve $1 billion in revenue by 2027 through organic growth, acquisitions, and high-margin product expansion.

Telecommunications Services Division (Communications):Includes VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform.
Fintech Division (Financial Freedom):Provides remittance services, top-up services, a MasterCard Debit Card, US bank accounts (no SSN required), and a Mobile App.
Electric Vehicles (EV) Division (Mobility):Offers Electric Motorcycles and plans to launch a Mid-Speed Car.
Artificial Intelligence (AI) Services Division (Information and Content):Provides AI solutions for unified customer engagement across web and phone channels, along with a white-label platform offering seamless access to services, entertainment, and support in a virtual 3D interface.
Cybersecurity Services:Through a new partnership with Cycurion, iQSTEL will offer advanced cybersecurity solutions, including 24/7 monitoring, threat detection, incident response, vulnerability assessments, and compliance management, providing essential protection to telecommunications clients and beyond.
iQSTEL has completed 11 acquisitions since June 2018 and continues to develop an active pipeline of potential future acquisitions, further expanding its suite of products and services both organically and through mergers and acquisitions.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

https://c212.net/c/img/favicon.png?sn=FL00432&sd=2025-01-21 View original content to download multimedia:https://www.prnewswire.com/news-releases/iqst---iqstel-releases-2025-shareholder-letter-highlighting-strategic-growth-ma-2025-campaign-and-vision-for-a-1-billion-corporation-future-302355880.html

SOURCE iQSTEL

[I am done]

$CBDW A Game-Changer for Smaller AI Companies Like 1606 Corporation
Trump’s $500 Billion AI Infrastructure Investment
https://cbdw.ai/trumps-500-billion-ai-infrastructure-investment-a-game-changer-for-smaller-ai-companies-like-1606-corporation/

[ANTI-BAGHOLDER]

MONI- We're thrilled to share the latest updates to MyPressAlert! Between January 2 and January 21, 2025, we rolled out several enhancements aimed at making your experience faster, more intuitive, and more insightful.

[Budots]

$AMOD secured its 9th patent, further advancing its offering in the multi-billion dollar industry. https://www.benzinga.com/partner/emerging-markets/25/01/42943192/alpha-modus-cements-its-position-in-the-ai-driven-advertising-market-with-9th-patent

[Budots]

$ASII proudly announces another milestone: GlobeTopper achieved $4.3 million in revenue for December 2024. https://finance.yahoo.com/news/globetopper-achieves-record-4-3m-130000925.html

[ProfitScout]

$CBDW News: 1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's groundbreaking announcement of Trapicolast, a pioneering antimalarial drug developed through its innovative AI-powered Sutra™ platform. This breakthrough medication targets dual mechanisms within the Plasmodium parasite, marking a significant advancement in the fight against malaria, particularly in regions with rising drug resistance.

A New Era in Malaria Treatment

Trapicolast introduces a novel and highly effective treatment for malaria by focusing on the apicoplast - an essential organelle within the Plasmodium parasite that has been largely overlooked in traditional antimalarial therapies. By targeting the apicoplast's DNA synthesis and vesicular trafficking pathways, Trapicolast disrupts the parasite's ability to survive and reproduce, providing a robust defense against drug-resistant malaria strains.

The creation of Trapicolast underscores the transformative power of artificial intelligence in drug discovery. Utilizing the Sutra™ AI platform, Adnexus analyzed over 8 million molecular compounds to identify ADX1 and ADX2, which led to the development of this groundbreaking treatment. This AI-driven approach not only accelerates drug discovery but also makes the process more cost-effective, opening the door to faster and more efficient treatments for diseases like malaria.

In regions such as Sub-Saharan Africa and Southeast Asia, where resistance to existing treatments is becoming an escalating concern, Trapicolast offers a promising new solution with its dual-target mechanism. This breakthrough provides renewed hope in the battle against malaria, one of the world's most prevalent infectious diseases.

Dual-Target Mechanism: Overcoming Resistance

The distinctive dual-target approach of Trapicolast is central to its efficacy:

Apicoplast Targeting: For the first time, a malaria treatment effectively targets the apicoplast, an organelle crucial for the parasite's survival, offering a new therapeutic option where current treatments have failed.

Vesicular Trafficking Disruption: By disrupting vesicular trafficking within the parasite, Trapicolast further enhances its effectiveness and reduces the likelihood of developing drug resistance.

This innovative dual approach is poised to have a significant impact in high-transmission areas where resistance to existing therapies is most prevalent.

Quote from CEO Austen Lambrecht

Austen Lambrecht, CEO of 1606 Corp., commented: "We are thrilled to support Adnexus Biotechnologies in the launch of Trapicolast. This represents a tremendous leap forward in the fight against malaria, showcasing how AI can drive innovation and deliver real-world solutions for global health challenges. Adnexus' use of its Sutra™ AI platform to discover a treatment that addresses both apicoplast targeting and vesicular trafficking is a prime example of how artificial intelligence is transforming medicine.

Commitment to Innovation and Growth

The potential strategic investment by 1606 Corp. in Adnexus aligns with our long-term vision to invest in cutting-edge AI health technologies that are poised for significant growth. Adnexus previously signed a Letter of Intent with 1606 Corp. for a strategic investment by 1606 Corp. in Adnexus. The LOI terminated on November 28, 2024 but the parties are still moving forward to close the transaction. We are confident that Adnexus' focus on AI-driven diagnostic tools and personalized health insights will play an essential role in advancing healthcare practices and improving patient outcomes.

Visionary Insights from Adnexus Leadership

Dr. Kirsten Bischof, a distinguished member of Adnexus's Advisory Board and co-inventor, stated, "We have unlocked a new frontier in drug discovery by targeting the apicoplast to bypass resistance, potentially saving countless lives in regions heavily affected by malaria. Given the severe impact of malaria in high-transmission areas such as Africa and Asia, this innovation offers a more effective and sustainable management strategy, bringing hope for saving many lives. This is not just science; it is a beacon of hope."

Dr. Gaurav Chandra, CEO of Adnexus, exclaims, "The discovery of Trapicolast via our Sutra™ AI platform isn't just an advancement; it's a revolution. It showcases our commitment to pushing the boundaries of what's possible in medical science, promising a future where malaria might no longer claim lives. It also validates the potential of the Sutra™ AI platform in drug discovery." He further added." While meeting our milestones for our HIV assets is a priority, we will further advance this Malaria drug in collaboration with our partners in India with access to specific models and resistant strains."

About 1606 Corp.

1606 Corp. is a leading innovator in AI-driven customer service solutions, focused on transforming digital marketplaces through advanced technologies. The company's strategic investment target Adnexus Biotechnologies, highlight its commitment to fostering innovation in medical science. By supporting the development of cutting-edge AI-powered healthcare solutions, 1606 Corp. aims to accelerate the adoption of transformative technologies that improve health outcomes and save lives worldwide.

Market Insights

AI in Drug Discovery: AI's role in drug discovery continues to expand, with increasing adoption across pharmaceutical companies seeking to accelerate the development of new treatments for diseases like malaria and HIV.

Forward-Looking Statements

This press release contains forward-looking statements regarding the development and potential impact of Trapicolast, the role of AI in drug discovery, and the future of Adnexus Biotechnologies' work in infectious disease treatments. These statements are based on current assumptions and projections, and actual results may differ due to various risks and uncertainties.

Contact Information:

Austen Lambrecht
CEO, 1606 Corp.
[e-mail]
cbdw.ai

SOURCE: 1606 Corp.
View the original press release on accesswire.com

[glenn1919]

HAO.......GVH.........https://stockcharts.com/h-sc/ui?s=HAO&p=D&yr=0&mn=2&dy=12&id=p84071410134

[I am done]

$CBDW 1606 Corp. Issue a statement in support of Adnexus Biotechnologies Inc.,
https://www.accesswire.com/956480/1606-corp-expresses-strong-support-for-adnexus-biotechnologies-groundbreaking-ai-technology

[I am done]

$UCLE In 2019 US Nuclear Invested In Fusion Energy MIFTI / MIFTEC
https://kingofpennystock.com/f/in-2019-us-nuclear-corp-invested-in-fusion-energy-mifti-miftec

[Crazedcracker]

$HAO Shorts in full control but should breakout eventually,$GVH micro float that's under the radar but skyrockets with significant volume....both are primed and ready

[Swammmie1040]

$SINC incredible story starting here better go to DD 1.577 billion OS 900 million of it restricted….

[Four by Two]

SING ready to blast off 🚀

[Four by Two]

SING ready to blast off 🚀

[Golden Cross]

$ILLR Triller has what it takes to dominate social media in light of the upcoming TikTok ban. https://www.foxbusiness.com/video/6351757905112

[I am done]

$UCLE Q3 Financial Turnaround:
https://www.globenewswire.com/news-release/2024/11/19/2983615/0/en/US-Nuclear-Announces-a-Significant-Improvement-in-3rd-Quarter-Financials.html

[I am done]

$AURI AURI NFT and Crypto Currency New Products
https://www.accesswire.com/942523/auri-nft-and-crypto-currency-new-products

[Zardiw]

$DDAmanda Chart on $BTCWF:

Questions/Support: 760 702-2009 - [e-mail]

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php



Z

[I am done]

$RJDG RJD Green Inc. CEO Ron Brewer updates shareholders on 2024 fiscal year-ended August 31, 2024 results and targeted 2025 growth.
https://finance.yahoo.com/news/rjd-green-inc-management-discusses-143000949.html